News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
111,818 Results
Type
Article (7349)
Company Profile (50)
Press Release (104419)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (35161)
Career Advice (1074)
Deals (5222)
Drug Delivery (11)
Drug Development (12981)
Employer Resources (49)
FDA (2155)
Job Trends (3042)
News (56022)
Policy (4192)
Tag
Academia (822)
Accelerated approval (1)
Adcomms (1)
Allergies (9)
Alliances (11146)
ALS (15)
Alzheimer's disease (262)
Antibody-drug conjugate (ADC) (22)
Approvals (2156)
Artificial intelligence (92)
Autoimmune disease (3)
Automation (6)
Bankruptcy (24)
Best Places to Work (2725)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (42)
Bladder cancer (21)
Brain cancer (6)
Breast cancer (61)
Cancer (499)
Cardiovascular disease (24)
Career advice (865)
Career pathing (16)
CAR-T (29)
Cell therapy (84)
Cervical cancer (1)
Clinical research (9980)
Collaboration (277)
Compensation (73)
Complete response letters (3)
COVID-19 (444)
CRISPR (11)
C-suite (64)
Cystic fibrosis (31)
Data (443)
Depression (6)
Diabetes (28)
Diagnostics (1396)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (42)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (9)
Earnings (9637)
Editorial (2)
Employer branding (8)
Employer resources (41)
Events (15466)
Executive appointments (197)
FDA (2345)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (191)
Gene editing (29)
Generative AI (10)
Gene therapy (58)
GLP-1 (86)
Government (639)
Guidances (12)
Healthcare (3347)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (20)
Indications (4)
Infectious disease (467)
Inflammatory bowel disease (31)
Inflation Reduction Act (2)
Influenza (8)
Intellectual property (16)
Interviews (189)
IPO (2733)
IRA (4)
Job creations (430)
Job search strategy (704)
Kidney cancer (3)
Labor market (12)
Layoffs (56)
Leadership (6)
Legal (651)
Liver cancer (8)
Lung cancer (59)
Lymphoma (31)
Machine learning (3)
Management (15)
Manufacturing (56)
MASH (19)
Medical device (1430)
Medtech (1430)
Mergers & acquisitions (2602)
Metabolic disorders (90)
Multiple sclerosis (14)
NASH (5)
Neurodegenerative disease (18)
Neuropsychiatric disorders (2)
Neuroscience (362)
NextGen: Class of 2025 (1093)
Non-profit (841)
Now hiring (9)
Obesity (40)
Opinion (57)
Ovarian cancer (19)
Pain (10)
Pancreatic cancer (15)
Parkinson's disease (30)
Partnered (4)
Patents (36)
Patient recruitment (16)
Peanut (6)
People (12643)
Pharmaceutical (7)
Pharmacy benefit managers (1)
Phase I (3334)
Phase II (4391)
Phase III (3191)
Pipeline (224)
Policy (21)
Postmarket research (349)
Preclinical (1965)
Press Release (38)
Prostate cancer (20)
Psychedelics (2)
Radiopharmaceuticals (35)
Rare diseases (80)
Real estate (853)
Recruiting (23)
Regulatory (3191)
Reports (11)
Research institute (743)
Resumes & cover letters (257)
RNA editing (2)
RSV (5)
Schizophrenia (8)
Series A (37)
Series B (27)
Service/supplier (1)
Sickle cell disease (12)
Special edition (4)
Spinal muscular atrophy (31)
Sponsored (9)
Startups (910)
Supply chain (8)
Tariffs (8)
The Weekly (2)
Vaccines (114)
Venture capitalists (10)
Weight loss (17)
Women's health (4)
Worklife (6)
Date
Today (33)
Last 7 days (155)
Last 30 days (532)
Last 365 days (6338)
2025 (2008)
2024 (6974)
2023 (8163)
2022 (10153)
2021 (11091)
2020 (9828)
2019 (8440)
2018 (6205)
2017 (5786)
2016 (5531)
2015 (5909)
2014 (4011)
2013 (3171)
2012 (3389)
2011 (3821)
2010 (3193)
Location
Africa (177)
Alabama (3)
Alaska (4)
Arizona (25)
Arkansas (4)
Asia (6204)
Australia (1097)
California (1518)
Canada (362)
China (79)
Colorado (19)
Connecticut (57)
Delaware (28)
Europe (16875)
Florida (88)
Georgia (21)
Idaho (7)
Illinois (66)
India (7)
Indiana (24)
Iowa (3)
Japan (36)
Kansas (8)
Kentucky (1)
Louisiana (2)
Maine (5)
Maryland (121)
Massachusetts (1062)
Michigan (19)
Minnesota (36)
Missouri (18)
Montana (6)
Nebraska (3)
Nevada (5)
New Hampshire (5)
New Jersey (293)
New Mexico (7)
New York (317)
North Carolina (120)
North Dakota (3)
Northern California (699)
Ohio (57)
Oklahoma (4)
Oregon (15)
Pennsylvania (131)
Puerto Rico (1)
Rhode Island (6)
South America (213)
South Carolina (3)
Southern California (577)
Tennessee (7)
Texas (118)
United States (4308)
Utah (31)
Virginia (31)
Washington D.C. (6)
Washington State (142)
West Virginia (1)
Wisconsin (12)
111,818 Results for "applied biology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025
April 28, 2025
·
5 min read
Biotech Bay
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
Cytokinetics, Incorporated announced that the Company will host the muscle biology-focused Contemporary Landscapes in Muscle Biology Research Symposium , May 17th, 2024 at the Mission Bay Conference Center in San Francisco.
May 17, 2024
·
5 min read
Career Advice
Computational Biology, Data Science Hot Areas for Oncology R&D Hiring
As market values increase for computational biology and data science, biopharma companies are looking to hire R&D professionals in those areas. A biotech talent acquisition expert shares his insights on these in-demand roles.
January 2, 2025
·
5 min read
·
Angela Gabriel
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
April 14, 2025
·
10 min read
Press Releases
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
April 3, 2025
·
5 min read
Press Releases
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
April 8, 2025
·
2 min read
Press Releases
PredxBio and Hamamatsu Photonics Announce Strategic Partnership to Deliver Next-Generation Spatial Biology Solutions for Cancer Research and Therapeutic Development
April 28, 2025
·
3 min read
Executive Appointments
After Month of Bad News, Applied Shuffles Leadership, Lays Out Uncertain Path for Rare Disease Drug
Following a 90% drop in share price due to an FDA rejection and a warning letter over Applied Therapeutics’ conduct during a clinical trial, the biotech’s CEO has stepped aside.
December 23, 2024
·
2 min read
·
Annalee Armstrong
1 of 11,182
Next
